Stock listing

44R1 Stock Price, News, Filings & Events — Phio Pharmaceuticals Corp.

Selected listing: 44R1 · MUN · EUR · DE

This page tracks Phio Pharmaceuticals Corp.'s 44R1:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 44R1:MUN. 44R1:MUN is the stock-level entry point for investors researching Phio Pharmaceuticals Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Phio Pharmaceuticals Corp. (Ticker: PHIO) is a public company based in the United States, focusing on innovative therapies in the pharmaceutical sector. With a market capitalization of approximately $12.08 million, Phio is dedicated to advancing its research and development efforts. The company aims to provide effective treatment solutions through its proprietary technology platform.

44R1:MUNEURDEUpdated September 11, 2026
Phio Pharmaceuticals Corp. logo
Ticker
44R1:MUN
Asset type
Stock
Market cap
$12.0M
Sector
Health Technology
Industry
Biotechnology
Exchange
MUN
Currency
EUR

Phio Pharmaceuticals Corp. 44R1:MUN stock context

This page tracks Phio Pharmaceuticals Corp.'s 44R1:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 44R1:MUN. 44R1:MUN is the stock-level entry point for investors researching Phio Pharmaceuticals Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Phio Pharmaceuticals Corp. (Ticker: PHIO) is a public company based in the United States, focusing on innovative therapies in the pharmaceutical sector. With a market capitalization of approximately $12.08 million, Phio is dedicated to advancing its research and development efforts. The company aims to provide effective treatment solutions through its proprietary technology platform.

Latest news from Phio Pharmaceuticals Corp.

All Phio Pharmaceuticals Corp. news →

Research Phio Pharmaceuticals Corp.

Alternate listings